CD5 CJC-1295 with DAC 5mg × 10 Vials white lyophilized powder vial label

CJC-1295 10mg peptide vial - transparent

CJC-1295 with DAC 5mg

Name: CJC-1295 with DAC 5mg - PeptaCo
SKU: CD5

CJC-1295 with DAC 5mg (Catalog No. CD5) is a research-grade GHRH analog with Drug Affinity Complex supplied by PeptaCo for qualified laboratory applications. This catalog specification provides 5mg per vial in lyophilized powder format. CJC-1295 with DAC is widely referenced in sustained GH release research. PeptaCo supplies this peptide with batch-specific documentation and COA available upon request.

Cat. No. CD5

Specification 5mg × 10 vials

Form Lyophilized powder

Category Growth Hormone Peptides

Request a Quote Request Current COA

Documentation support COA upon request

B2B supply Bulk quotation available

Traceability Batch-specific records

Important Note

This product is intended for qualified laboratory research and analytical applications. It is not for human or veterinary use. Specifications and documentation vary by batch — please contact PeptaCo for the current batch information.

Molecular Profile

What is CJC-1295 with DAC?

CJC-1295 with DAC (Drug Affinity Complex) is a long-acting synthetic GHRH analog studied in growth hormone secretion research. The DAC modification extends its research half-life. PeptaCo supplies this compound for qualified laboratory studies.

This listing covers the 5mg × 10 vials configuration under catalog number CD5. Appearance, analytical results, counter-ion information, and other release specifications should be confirmed against the certificate issued for the current batch.

Compound data

Chemical Structure & Purity Profile

Purity >99% Peptide Content >98%

Chemical Structure

PubChem CID 91971820

View CJC-1295 with DAC PubChem record

Type	GHRH analog with DAC
PubChem CID	91971820
HPLC Purity	>99% (batch-specific COA available)
Peptide Content	>98% peptide content — not just chromatographic purity
Documentation	Current batch COA and analytical package available upon request

Why peptide content matters: some suppliers may report high chromatographic purity while delivering lower actual peptide content. PeptaCo specifies both >99% purity and >98% peptide content for qualified B2B supply.

Product Specifications

Product Name	CJC-1295 with DAC
Catalog Number	CD5
Specification	5mg × 10 vials
Product Form	Lyophilized powder
Category	Growth Hormone Peptides
Documentation	Batch-specific COA available upon request
Storage	Refer to batch-specific product documentation
Intended Market	Qualified B2B and research customers

Quality & Analytical Documentation

Batch-specific analytical documentation is available to qualified customers upon request. Contact PeptaCo with the product SKU and required quantity to request the current documentation package.

◦ Identity Confirmation — available by request

◦ Purity Analysis — available by request

◦ Batch Traceability — provided with every order

◦ Additional Testing — product- and batch-dependent

Need Current Batch Documentation or Bulk Pricing?

Tell us the product SKU, quantity, documentation requirements, and destination country. The PeptaCo team will prepare the applicable quotation and document package.

Request a Quote Ask About OEM/ODM

Description
Reviews (0)

Description

Product Overview

CJC-1295 with DAC (Drug Affinity Complex) is a modified growth hormone-releasing hormone (GHRH) analog supplied by PeptaCo for qualified laboratory research. The DAC modification extends the peptide’s plasma half-life through albumin binding, making it a valuable tool for studying sustained GH release mechanisms in research settings.

Key Product Details

Product Name: CJC-1295 with DAC
Specification: 5mg per vial
Product Form: Lyophilized powder
Category: GH Secretagogue Research Peptides
Modification: Drug Affinity Complex (DAC) for extended half-life

Chemical Identity

CJC-1295 with DAC is a 30-amino-acid GHRH analog with a C-terminal DAC modification. The DAC moiety enables reversible albumin binding, significantly extending the peptide’s biological half-life compared to unmodified GHRH analogs. This listing covers the 5mg specification under catalog number CD5.

Research Context

CJC-1295 with DAC is widely referenced in GH research for investigating sustained growth hormone release patterns, receptor desensitization studies, and dose-response relationships. The DAC modification makes it particularly useful for research requiring prolonged peptide exposure. PeptaCo supplies this compound in high-purity format for qualified laboratory customers.

Storage and Handling

Store in a cool, dry place away from direct light. Follow batch-specific storage instructions provided with the certificate of analysis. Avoid repeated freeze-thaw cycles. Handle using standard laboratory practices.

Documentation and Quality

Batch-specific analytical documentation is available to qualified customers upon request. Contact PeptaCo with the product SKU and required quantity to request the current documentation package, which may include identity confirmation, purity analysis, and batch traceability records.

Important Notice

This product is supplied for qualified laboratory research and analytical applications only. It is not for human or veterinary use. Product specifications may vary by batch. Appearance, analytical results, counter-ion information, and other release specifications should be confirmed against the certificate issued for the current batch.

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 with DAC 5mg”